What question did this study set out to answer?

To evaluate clinical outcomes following bilateral implantation of the AcrySof IQ Vivity IOL in cataract surgery.

Clinical outcomes of bilateral implantation of a new non-diffractive extended-vision intraocular lens (AcrySof ® IQ vivity)

View Full Paper

Ask AI

Bookmark

To evaluate clinical outcomes following bilateral implantation of the AcrySof IQ Vivity IOL in cataract surgery.
Retrospective unmasked nonrandomized case series
Patients underwent phacoemulsification and implantation of AcrySof IQ Vivity IOL
Targeted minimonovision approach in nondominant eye
Assessment of visual outcomes and patient-reported satisfaction post-operatively
Analysis of visual disturbances using systematic questionnaires
181 patients enrolled with excellent patient-reported outcomes
Mean binocular uncorrected distance visual acuity was −0.01 logMAR
Mean binocular uncorrected near visual acuity was 0.16 logMAR
Mean spherical equivalent of −0.27D and residual astigmatism of 0.3D in toric group
High levels of spectacle independence reported with minimal visual disturbances

No takes yet. Share an insight, caveat, or question.

Retrospective case series found high patient satisfaction and minimal visual disturbances after cataract surgery with AcrySof IQ Vivity IOL.

Costa et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Retrospective case series found high patient satisfaction and minimal visual disturbances after cataract surgery with AcrySof IQ Vivity IOL.